Salesforce Shares Decline on Soft Revenue Outlook Amid Persistent AI Disruption Concerns Dating Startups Tackle Fake Profiles New Tech Promises Authentic Connections Cramer Comments on Atlassians YouTube Controversy Amid Steep Stock Decline Solana SOL LongTerm Outlook Key Factors Shaping the Next Five Years New York Fed Study Reveals Surging Gas Prices Disproportionately Impact LowerIncome Households Packaging Corporation of America Analysts Weigh In on Containerboard Outlook Penumbra Q1 2026 Earnings EPS Misses Estimates Stock Edges Higher SDRL Q1 2026 Earnings NarrowerthanExpected Loss Boosts Investor Sentiment Avalo Therapeutics Inc AVTX Q1 2026 Earnings NarrowerThanExpected Loss Marks Continued Progress for ClinicalStage Biotech PZG Q1 2026 Earnings Significant EPS Miss Reflects PreRevenue Exploration Stage Enlight Renewable Energy Ltd ENLT Q1 2026 Earnings Positive EPS Surprise Amid Limited Visibility BLMN Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiency Fortive FTV Dips 157 as Industrial Sector Faces Headwinds Key Levels to Watch Carrier Global Pulls Back Slightly as Shares Hold Above Key Support Grindr Inc GRND Holds Steady Near Support Amid Modest Pullback Pulmatrix PULM Experiences Modest Decline Amid Tight Trading Range Davis Commodities Limited DTCK Holds Steady at 100 Consolidation Phase for Commodity Player Professional Title Gen Z Faces Diminishing Returns on Higher Education Amid Broader Economic Instability IPM Q1 2026 Earnings Significant Earnings Miss Amidst Strategic Transformation Royalty Pharma RPRX Edges Higher Testing Resistance Near 57 Amid Steady Gains COFS Q1 2026 Earnings EPS Beats Estimates by 55 Amid Mixed Market Reaction Gossamer Bio Q1 2026 Earnings WiderThanExpected Loss as No Revenue Generated LOW Q1 2026 Earnings EPS Beats Estimates Amid Challenging Macro Environment PFLT Q1 2026 Earnings EPS Misses Estimates as Net Investment Income Falls Short SNCY Q1 2026 Earnings EPS Miss Weighs on Market Sentiment as Revenue Figures Remain Undisclosed CLNN Q1 2026 Earnings Narrowed Loss Beats Expectations Amid Ongoing Clinical Progress DORM Q1 2026 Earnings Earnings Miss Estimates Stock Edges Lower